Australia is working alongside many of regional neighbours to provide end-to-end support in rolling out the COVID-19 vaccines.
Vaccine regulation and safety
Any vaccines procured by Australia will meet rigorous, internationally-accepted standards of safety and efficacy. Australia is playing a pivotal role in ensuring the safety and effectiveness of vaccines across the Pacific and in key partner countries in Southeast Asia.
This includes providing technical support for countries on regulatory requirements for COVID-19 vaccine safety and efficacy, drawing on expertise within key Australian institutions such as the Therapeutic Goods Administration (TGA). TGA, WHO and other recognised Stringent Regulatory Authorities are among the agencies Australia will rely on to ensure vaccines are approved for use before delivery in-country. These are the same processes Australia is using domestically.
Vaccine delivery and monitoring
The Regional COVID-19 Vaccine Access and Health Security Initiative will provide technical assistance for our neighbours to deliver successful COVID-19 immunisation programs.
This includes support for immunisation policy and planning, focusing on technical requirements such as cold chain and distribution logistics, public communication campaigns, and capacity building in vaccine quality and safety assurance.
Australia’s approach to the roll-out of the vaccine is evidenced-based, drawing on local, national and international expertise. This ensures the purchasing, transportation, and roll-out of the vaccines are based on sound expertise and contextual knowledge, noting the specifics of vaccine allocation in-country will be led by partner governments.
Our commitment to ensure inclusive access to vaccines
The Australian Government is committed to supporting access to safe, effective and affordable COVID-19 vaccines for all sectors of our regional communities throughout the Pacific and Southeast Asia. An inclusive recovery from the pandemic is dependent on us ensuring that no one is left behind. We will work with partners to ensure consideration of equity issues including gender, disability and social inclusion across the vaccine initiative. We recognise the importance of meaningful and inclusive consultation and the full and equal participation of all groups, particularly those who may be disproportionately impacted by the pandemic itself and face greater barriers to safely accessing care and support including vaccines.